» Articles » PMID: 38393488

Pleomorphic Adenoma with a Novel Gene Rearrangement-LINC01606::PLAG1

Overview
Specialties Oncology
Pathology
Date 2024 Feb 23
PMID 38393488
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pleomorphic adenoma is a well-known benign salivary gland neoplasm characterized by the presence of varying proportions of three different components, including bi-layered ducts, myoepithelial cells, and admixed within a chondromyxoid/fibrous stroma.

Method: We report an interesting case of an adult male who presented with bleeding from an extensively degenerated parotid gland mass, concerning for a vascular neoplasm versus primary malignant tumor. Microscopically, majority of the viable tumor exhibited diffuse proliferation of spindle to epithelioid cells, with focal areas depicting cribriform glands, ducts, and scant chondromyxoid stroma.

Result: Next-generation sequencing (NGS) RNA-based fusion panel analysis identified a gene rearrangement involving the pleomorphic adenoma gene 1 (PLAG1), with a novel, cryptogenic fusion partner known as LINC01606; [LINC01606::PLAG1; inv(8;8)(8q12.1;8q12.1)].

Conclusion: To the best of our knowledge, this is the first documented case of a long non-coding RNA (lnc-RNA) serving as a rearrangement partner with the PLAG1 gene. We reviewed the molecular characteristics of this entity and explored the potential role of LINC01606::PLAG1 in the tumorigenesis of pleomorphic adenoma.

References
1.
Antony J, Gopalan V, Smith R, Lam A . Carcinoma ex pleomorphic adenoma: a comprehensive review of clinical, pathological and molecular data. Head Neck Pathol. 2011; 6(1):1-9. PMC: 3311945. DOI: 10.1007/s12105-011-0281-z. View

2.
Chen Y, Lin C, Lai S, Chen C, Wang W, Lin Y . Pleomorphic adenoma with extensive necrosis: report of two cases. Oral Dis. 2004; 10(1):54-9. DOI: 10.1046/j.1354-523x.2003.00966.x. View

3.
Quinn J, Chang H . Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 2015; 17(1):47-62. DOI: 10.1038/nrg.2015.10. View

4.
Griffith C, Schmitt A, Little J, Magliocca K . New Developments in Salivary Gland Pathology: Clinically Useful Ancillary Testing and New Potentially Targetable Molecular Alterations. Arch Pathol Lab Med. 2017; 141(3):381-395. DOI: 10.5858/arpa.2016-0259-SA. View

5.
Skalova A, Stenman G, Simpson R, Hellquist H, Slouka D, Svoboda T . The Role of Molecular Testing in the Differential Diagnosis of Salivary Gland Carcinomas. Am J Surg Pathol. 2017; 42(2):e11-e27. DOI: 10.1097/PAS.0000000000000980. View